Concentra Group Holdings Parent vs Sotera Health
CON and SHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CON and SHC compare
Concentra Group Holdings Parent and Sotera Health are about the same size, with market caps of $5.4B and $4.7B.
On earnings, Concentra Group Holdings Parent is cheaper: it trades at 25.3× trailing earnings, against 29.1× for Sotera Health.
Concentra Group Holdings Parent grew revenue faster over the last twelve months (11.8% versus 8.1% for Sotera Health).
Sotera Health keeps more of each dollar of sales as profit, with a net margin of 13.4% compared with 9.3% at Concentra Group Holdings Parent.
Concentra Group Holdings Parent pays a dividend yielding 0.59%; Sotera Health does not pay one.
Concentra Group Holdings Parent scores higher on the StockData Score (12 against 7 for Sotera Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CON | SHC |
|---|---|---|
| Size and price | ||
| Market cap | $5.4B | $4.7B |
| Share price | $42.55 | $16.61 |
| Change, 1 year | 113% | 2.2% |
| Change, 5 years | – | −26.3% |
| Beta (5Y) | 0.49 | 1.59 |
| Employees | 13K | 3,000 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 2 | 2 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 25.3× (better) | 29.1× |
| P/S | 2.3× (better) | 3.9× |
| P/B | 10.7× | 7.1× (better) |
| EV/EBITDA | 14.4× | – |
| P/FCF | 21.1× (better) | 42.1× |
| FCF yield | 4.7% (better) | 2.4% |
| Fair value | $36.36 | – |
| Margin of safety | −17.0% | – |
| Growth | ||
| Revenue growth (TTM) | 11.8% (better) | 8.1% |
| Revenue growth, 5Y average | – | 7.3% |
| Net income growth (TTM) | 41.2% | 581% (better) |
| EPS growth (TTM) | 40.0% | 613% (better) |
| Profitability | ||
| Gross margin | 29.9% | 55.0% (better) |
| Operating margin | 16.9% | – |
| Net margin | 9.3% | 13.4% (better) |
| FCF margin | 11.0% (better) | 9.3% |
| Return on equity | 48.5% (better) | 27.8% |
| Return on invested capital | 15.6% | – |
| Financial health | ||
| Debt / equity | 3.00 (better) | 3.21 |
| Net debt / EBITDA | 3.02 | – |
| Current ratio | 1.30 | 2.80 (better) |
| Altman Z-score | 2.71 (better) | 1.40 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.59% | – |
| Payout ratio | 14.8% | – |
| Years of dividend growth | 1 | – |
| Buyback yield | 1.5% | – |
| Shareholder yield | 2.1% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 88.2% | 103% |
| Held by insiders | 11.3% | – |
| Insider net buying, 12 months | −$14.6M (better) | −$1.8B |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.0% | – |
Go deeper
- CON stock overview
- CON income statement
- CON valuation and score
- SHC stock overview
- SHC income statement
- SHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.